Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American College of Cardiology

• Publication date

  2003-03-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(02)02972-8PMID 12651051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombosis and Hemorrhage

  2002cited by this paper
• Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

  2001cited by this paper
• Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects.

  2001cited by this paper
• Diabetes and cardiovascular disease

  2000cited by this paper
• Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

  2000cited by this paper
• Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis

  2000cited by this paper
• Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

  2000cited by this paper
• Platelets Release their Lysosomal Content In Vivo in Humans upon Activation

  2000influential reference
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

  1999cited by this paper
• In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.

  1999cited by this paper
• A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials.

  1999cited by this paper
• In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

  1999cited by this paper
• Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

  1998cited by this paper
• Platelet Activation Markers in Patients with Peripheral Arterial Disease

  1997cited by this paper
• Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

  1997cited by this paper
• Mechanisms Initiating Platelet Thrombus Formation

  1997cited by this paper
• Reduced Effect of Aspirin on Thrombus Formation at High Shear and Disturbed Laminar Blood Flow

  1996cited by this paper
• Effects of Recent, Short-Term Hyperglycemia on Responses to Hypoglycemia in Humans: Relevance to the Pathogenesis of Hypoglycemia Unawareness and Hyperglycemia-Induced Insulin Resistance

  1995cited by this paper
• Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.

  1995cited by this paper
• Interferon-Alpha Is Effective in the Treatment of HIV-1Related, Severe, Zidovudine-Resistant Thrombocytopenia: A Prospective, Placebo-controlled, Double-Blind Trial

  1994cited by this paper
• Mechanisms of Shear-induced Platelet Adhesion and Aggregation

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Platelets in Diabetes: The Role in the Hemostatic Regulation in Atherosclerosis

  1993cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Direct detection of activated platelets and platelet-derived microparticles in humans.

  1990cited by this paper
• Thromboxane biosynthesis and platelet function in type II diabetes mellitus.

  1990cited by this paper
• Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitus.

  1990cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Shear stress activation of platelet glycoprotein IIb/IIIa

  1989cited by this paper
• Design and Analysis of Cross-Over Trials

  1989cited by this paper
• Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.

  1988cited by this paper
• Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

  1988cited by this paper
• Postchallenge Glucose Concentration and Coronary Heart Disease in Men of Japanese Ancestry: Honolulu Heart Program

  1987cited by this paper
• Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.

  1987cited by this paper
• Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease.

  1987cited by this paper
• Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.

  1987cited by this paper
• Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.

  1985cited by this paper
• Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.

  1983cited by this paper
• Increased platelet thromboxane synthesis in diabetes mellitus.

  1981cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics

  1977cited by this paper

• Obesity and type 2 diabetes mellitus add up to induce platelet hyperreactivity and platelet activation.

  2026cites this paper
• Independent and combined effects of mean blood glucose and glycemic variability on 28-day mortality in older acute myocardial infarction patients: a MIMIC-IV cohort study

  2025cites this paper
• Stress Hyperglycemia Ratio as a Predictor of In-Hospital Stent Thrombosis in STEMI Patients Undergoing Primary PCI: A Retrospective Cohort Study

  2025cites this paper
• The Association Between Stress Hyperglycemia Ratio and Short‐Term Outcomes After Successful Recanalization by Mechanical Thrombectomy in Acute Ischemic Stroke Patients

  2025cites this paper
• Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes

  2025cites this paper
• Stress hyperglycemia ratio: a novel prognostic marker in chronic kidney disease

  2025cites this paper
• Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes.

  2025cites this paper
• Associated factors of spontaneous reperfusion in patients with acute ST-segment elevation myocardial infarction before primary percutaneous coronary intervention

  2025cites this paper
• Prognostic value of baseline glucose levels for mortality in patients with cardiogenic shock: a systematic review and meta-analysis

  2025cites this paper
• The prognostic role of glycemic variability in predicting the risk of adverse cardiovascular events in patients with cardiovascular diseases: a meta-analysis

  2025cites this paper
• Evaluating thrombosis risk and patient-specific treatment strategy using an atherothrombosis-on-chip model.

  2024cites this paper
• Association between Relative Thrombocytosis and Microalbuminuria in Adults with Mild Fasting Hyperglycemia

  2024cites this paper
• Hyperglycemia and elevated C‐reactive protein are independent predictors of hospital mortality in hospitalized COVID‐19 patients in South‐Kivu, eastern Democratic Republic of the Congo: A cross‐sectional study

  2024cites this paper
• Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality.

  2024cites this paper
• The association between the stress hyperglycaemia ratio and mortality in cardiovascular disease: a meta-analysis and systematic review

  2024cites this paper
• Ward monitoring 4.0: real-time metabolic insights from continuous glucose monitoring into perioperative organ dysfunction.

  2024cites this paper
• Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity.

  2024cites this paper
• Distribution of pathogens and risk factors for post-replantation wound infection in patients with traumatic major limb mutilation

  2024cites this paper
• Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio.

  2023cites this paper
• Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis

  2023cites this paper
• Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review

  2023cites this paper
• Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy

  2023cites this paper
• Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

  2023cites this paper
• Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes

  2023cites this paper
• The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk

  2023cites this paper
• Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3

  2022cites this paper
• Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy.

  2022cites this paper
• Detection of Hemostasis Abnormalities in Type 2 Diabetes Mellitus Using Thromboelastography

  2022cites this paper
• Hyper-reactive platelets and type 2 diabetes.

  2022cites this paper
• Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability

  2022cites this paper
• Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke

  2022cites this paper
• Effects of whole blood storage in a polyolefin blood bag on platelets for acute normovolemic hemodilution

  2021cites this paper
• Shear Stress and Metabolic Disorders—Two Sides of the Same Plaque

  2021cites this paper
• Diabetes Detection and Sensor-Based Continuous Glucose Monitoring – A Deep Learning Approach

  2021cites this paper
• Admission hyperglycemia and all-cause mortality in diabetic and non-diabetic patients with acute myocardial infarction: a tertiary center analysis

  2021cites this paper
• Acute Occlusion of the Lower Limb Artery Associated with Hyperosmolar Hyperglycemic Nonketotic Coma in a Patient with Amyotrophic Lateral Sclerosis: A Case Report

  2021cites this paper
• Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

  2021cites this paper
• Hyperglycemia and Thrombocytopenia　― Combinatorially Increase the Risk of Mortality in Patients With Acute Myocardial Infarction Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation ―

  2021cites this paper
• High glucose removes natural anti-α-galactoside and anti-β-glucoside antibody immune complexes adhering to surface O-glycoproteins of normal platelets and enhances platelet aggregation

  2021cites this paper
• Predictors of outcome in diabetic patients undergoing infrapopliteal endovascular revascularisation for chronic limb-threatening ischaemia.

  2021cites this paper
• Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis.

  2021cites this paper
• The relationship between hemoglobin A1c levels and thrombus load in patients with type 2 diabetes mellitus and non-ST-segment elevation myocardial infarction

  2021cites this paper
• Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus

  2021cites this paper
• Diabetes-associated complications and some Indian traditional plants used for its management

  2020cites this paper
• Stress burden related to postreperfusion syndrome may aggravate hyperglycemia with insulin resistance during living donor liver transplantation: A propensity score-matching analysis

  2020cites this paper
• Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus

  2020cites this paper
• The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

  2020cites this paper
• Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement

  2020cites this paper
• Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts

  2020cites this paper
• Prognostic significance of relative hyperglycemia after percutaneous coronary intervention in patients with and without recognized diabetes.

  2020cites this paper
• Management of Hyperglycemic Hyperosmolar Syndrome

  2020cites this paper
• Association between Admission Hyperglycemia and Culprit Lesion Characteristics in Nondiabetic Patients with Acute Myocardial Infarction: An Intravascular Optical Coherence Tomography Study

  2020cites this paper
• Influence of Cardiometabolic Risk Factors on Platelet Function

  2020cites this paper
• Diabetes and Hyperglycemia Affect Platelet GPIIIa Expression: Effects on Adhesion Potential of Blood Platelets from Diabetic Patients under In Vitro Flow Conditions

  2020cites this paper
• Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia

  2020cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Increased platelet function during frailty.

  2019cites this paper
• Metabolic Havoc of Uncontrolled Diabetes

  2019cites this paper
• The impact of intraday glucose variability on coronary artery spasm in patients with dysglycemia

  2019cites this paper
• Diabetes Detection Using ECG Signals: An Overview

  2019cites this paper
• Blood-Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke

  2019cites this paper
• Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis

  2019cites this paper
• Implications of Blood Glucose Management with Heart Failure Patients with Type 2 Diabetes in an Acute Care Setting

  2019cites this paper
• STREPTOZOTOCIN-INDUCED DIABETES MELLITUS - A PARADOX OF HIGH INTRINSIC PLATELET REACTIVITY AND LOW IN VITRO PLATELET AGGREGATION.

  2019cites this paper
• PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention

  2019cites this paper
• Optimized Treatment of ST-Elevation Myocardial Infarction.

  2019cites this paper
• Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs.

  2019cites this paper
• Hyperglycemia

  2019cites this paper
• Berberine mitigates high glucose‐potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity

  2019cites this paper
• Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention

  2019cites this paper
• Lignans' potential in pre- and post-onset type 2 diabetes management.

  2019cites this paper
• Mitochondrial Calcium In Diabetic Platelets: Friend Or Foe?

  2018cites this paper
• Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

  2018cites this paper
• Ischemia/Reperfusion Damage in Diabetic Stroke

  2018cites this paper
• Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications

  2018cites this paper
• Perioperative glucose control

  2018cites this paper
• Impact of perioperative hyperglycemia in patients undergoing microvascular reconstruction

  2018cites this paper
• Diabetes and Platelet Response to Low-Dose Aspirin

  2018cites this paper
• Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.

  2018cites this paper
• Hyperglycemia is associated with cardiac complications in elderly nondiabetic patients receiving total parenteral nutrition

  2018cites this paper
• Value of High Sensitive CRP in Hyperglycemic Patients with Acute Coronary Syndrome

  2018cites this paper
• Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.

  2018cites this paper
• Blood–Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke

  2017cites this paper
• An Investigation into Gilbert’s Syndrome: Understanding the Role of Unconjugated Bilirubin in Targeting Platelet and Haemostatic Mechanisms Associated with Thrombotic Risk Factors

  2017cites this paper
• Thrombosis in diabetes: a shear flow effect?

  2017cites this paper
• Preprocedural Prediction Model for Contrast‐Induced Nephropathy Patients

  2017cites this paper
• HbA1c AS A PREDICTOR OF PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROME (ACS) AND ST ELEVATION MYOCARDIAL INFARCTION (STEMI) COMPARED TO FASTING AND ADMISSION GLUCOSE

  2017cites this paper
• Platelets and Diabetes

  2017cites this paper
• A study to find correlation of platelet indices with HbA1c in diabetic patients with absence/presence of vascular complications

  2017cites this paper
• Prevalence of Undiagnosed Diabetes Mellitus in Acute Coronary Syndrome Patients: A Hospital-based Study

  2017cites this paper
• Stress hyperglycemia in general surgery: Why should we care?

  2017cites this paper
• Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation

  2017cites this paper
• Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards

  2017cites this paper
• Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention

  2017cites this paper
• Non-diabetic clinical applications of insulin

  2016cites this paper
• Postprandial dysmetabolism: Too early or too late?

  2016cites this paper
• Pleiotropic Garlic ( Allium Sativum ) in the Treatment of Diabetes Mellitus and its Complications

  2016cites this paper
• A possible association between space weather conditions and the risk of acute coronary syndrome in patients with diabetes and the metabolic syndrome

  2016cites this paper
• P Myocardial Infarction yperglycemia Is an Important redictor of Impaired Coronary low Before Reperfusion Therapy in T-Segment Elevation Myocardial Infarction

  2016cites this paper
• Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling—Are Useful Drugs Already Available?

  2016cites this paper